TGR5 indirectly prevents the development of liver cancer by mainly improving metabolic syndrome; of course, TGR5 can also negatively regulate the transcriptional activity of NFκB factor, preventing chronic hepatitis disease (30). This evidence concerns the gene GPBAR1 and liver cancer.